key: cord-0888491-ulxmdco4
authors: Martinez-Fierro, Margarita L.; Ríos-Jasso, Jorge; Garza-Veloz, Idalia; Reyes-Veyna, Lucia; Cerda-Luna, Rosa Maria; Duque-Jara, Iliana; Galvan-Jimenez, Maribel; Ramirez-Hernandez, Leticia A; Morales-Esquivel, Andres; Ortiz-Castro, Yolanda; Gutierrez-Camacho, Jose R; Valdes-Aguayo, José J; Vargas-Rodriguez, Jose R
title: The role of close contacts of COVID-19 patients in the SARS-CoV-2 transmission: an emphasis on the percentage of non-evaluated positivity in Mexico
date: 2020-10-07
journal: Am J Infect Control
DOI: 10.1016/j.ajic.2020.10.002
sha: 8fe981e02d39695a50a3f753f39dadf727768651
doc_id: 888491
cord_uid: ulxmdco4

OBJECTIVES: To determine the percentage of positivity of close contacts of coronavirus disease 19 (COVID-19) patients to depict the importance of asymptomatic infections in the patient-to-patient transmission of COVID-19. METHODS: One hundred subjects were included. Nineteen index COVID-19 cases and eighty-one traced close contacts were screened for coronavirus 2 of severe acute respiratory syndrome (SARS-CoV-2) using real-time reverse transcription-polymerase chain reaction (RT-PCR). Immunoglobulin M (IgM) and G (IgG) against SARS-CoV-2 were evaluated by rapid test. RESULTS: Thirty-four (42%) contacts in the study were positive for SARS-CoV-2. Twenty-three (67.6%) manifested less than two respiratory symptoms, and five (14.7%) remained asymptomatic. The average of positive contacts by index COVID-19 case (R(0)) was 4.3 and the mean of time of positive COVID-19 test at sampling time was 18.9 days. Positive antibody test against SARS-CoV-2 was observed in 16% of the participants. CONCLUSION: The proportion of close contacts of COVID-19 patients infected with SARS-CoV-2 (42%) and with less than two or with no respiratory symptoms (82.4%) was high in the study population. A low proportion of COVID-19 patients had a positive test for antibodies against SARS-CoV-2. The screening for SARS-CoV-2 in close contacts of COVID-19 positive patients should be encouraged to avoid spreading the infection and the expansion of the disease.

-COVID-19 asymptomatic patients could become an important cause of virus spread.

-A high proportion (42%) of close contacts of COVID-19 patients were infected with SARS-CoV-2 -The average of contacts infected with SARS-CoV-2 by index COVID-19 case was 4.3.

-The mean of time of SARS-CoV-2 positive test was 18.9 days.

-82.4% of contacts infected with SARS-CoV-2 had less than two or had no respiratory symptoms. 

The coronavirus disease 19 (COVID 19) epidemic represents a health problem with the characteristics of contagiousness, quick transmission and general susceptibility. According with Johns Hopkins Center for Systems Science and Engineering data, to date, worldwide more than 32 million of cases have been confirmed, of which 979,701 cases died 1 . In Mexico up the end of 24 September 2020, the statistics showed 743,435 patients infected with SARS-CoV-2 and 76,647 deaths due to COVID-19 2 .

The coronavirus 2 of severe acute respiratory syndrome (SARS-CoV-2) infection is directly linked with the recognition and binding of its spike protein to the human angiotensin-converting enzyme 2 receptor 3 .

This receptor is mainly located in the lung alveolar epithelial cells, which are potentially target of this virus. As a result of a pro-inflammatory response, the SARS-CoV-2 may cause acute respiratory distress syndrome and in severe cases may result in fatal outcomes 4 . SARS-CoV-2 has a high homology with coronavirus of severe acute respiratory syndrome (SARS-CoV) and like SARS-CoV its transmission mode is human-to-human. The number of secondary cases produced by a single infected person with SARS-CoV-2 in a susceptible population (R 0 ) has been estimated to be between two and three, which is higher than that previously reported for SARS-CoV 5, 6 .

The fast capacity to spread of SARS-CoV-2 highlights the importance of having a sensitive and specific virus detection method. The gold standard for COVID-19 diagnosis is the molecular detection of the genome of SARS-CoV-2 in pharyngeal swab samples using a real-time reverse transcription-polymerase chain reaction (RT-PCR) assay. The enzyme-linked immunoassay (ELISA) for specific immunoglobulin M (IgM) and G (IgG) has been suggested as an acceptable choice to reduce the false negatives rate that could occur with the RT-PCR method 7 . In addition to an accurate method of detection, a good screening strategy should allow to break the channels of viral transmission. At this point, the person-to-person contact in the spread of disease has an important role, especially when asymptomatic infected patients are involved, because the absence of symptoms may lead to them not being screened and, therefore, remain undetected. Asymptomatic individuals represent a substantial fraction of the SARS-CoV-2 infected population estimated at 17.9% 8 . In a recent study Hu et al (2020), evaluated twenty-four asymptomatic COVID-19 infections from the screening of close contacts of COVID-19 patients in China. Nineteen patients remained asymptomatic during hospitalization and the median communicable period (defined as the interval from the first day of positive nucleic acid tests to the first day of continuous negative tests), was 9.5 days (up to 21 days among the twenty-four asymptomatic cases). These results suggest that infected asymptomatic close contacts, could become an important cause of virus transmission and, therefore, a strict monitoring of close contacts via multiple screening should be prioritized 7 .

Mexico is in phase three of the COVID-19 pandemic and since the first reported case (February 28, 2020), the Mexican government increased measures to contain the spread of the virus. These measures have included social distancing, closing schools, the obligatory use of mouth masks, and canceling massive events, among others 9, 10 . However, the SARS-CoV-2 screening tests in Mexico (until August 24, 2020), have been focused on people who met the operational criteria established by the Mexican Health Authority's consensus. These criteria included meeting two out of three of the following symptoms: fever ≥38°C, dry cough and/or headache, in addition to other COVID-19 related symptoms and the presence of a comorbidity 11, 12 . Considering the World Health Organization (WHO) recommendations regarding the need to increase the number of SARS-CoV-2 tests and the isolation and tracing of contacts, here, we conducted an investigation to evaluate the percentage of positive COVID-19 patients without diagnosis in Mexico because the total or partial absence of symptomatology in close contacts of COVID-19 patients 13 .

We sought to depict the importance of asymptomatic infections in the patient-to-patient transmission of COVID-19 and the relevance of tracing and testing close contacts to contain potential outbreaks.

The ethics committees of the Academic Unit of Human Medicine and Health Sciences from Universidad Autonoma de Zacatecas and the Alpha Medical Center approved this cross-sectional study carried out in Zacatecas, Mexico from June-July 2020 (Approval ID: AMCCI-FSARSC2-006 and 007). We retrospectively reviewed documents on epidemiological investigations of nineteen patients with laboratory test confirmation for COVID-19.

Using patients' epidemiological records, we traced eighty-one close contacts for medical evaluation and sampling. Indicated patients and their contacts (aged >18 years old) were contacted by telephone and invited to participate in the study. The patient recruitment was carried out in the Centro de Salud "Francisco Villa" from Secretaría de Salud de Zacatecas and in the Molecular Medicine Laboratory from the Academic Unit of Human Medicine and Health Sciences from Universidad Autónoma de Zacatecas.

A questionnaire consisting of demographic and clinical data and signs and symptoms related to COVID-19 was administered to the participants. There were no exclusion criteria for this study. A close contact was defined as an individual who has had closer than <6 feet for ≥15 min with people with a positive diagnosis for COVID-19, whether they were symptomatic or asymptomatic according to the Center for Disease Control and Prevention (CDC) definition 14 .

Throughout the protocol, the operational definition of suspicious case of COVID-19 was defined according to the Mexican Health Guidelines (august 24, 2020) as follows: a patient who met two out of three of the following symptoms: a fever ≥ 38°C, dry cough and/or headache, and have at least one other COVID-19 related symptoms (asthenia, odynophagia, myalgia, arthralgia, rhinorrhea, conjunctivitis, anosmia, dysgeusia, nausea, abdominal pain, and diarrhea) and underlying risk conditions (pregnancy, immunosuppression, previous lung disease, diabetes mellitus, systemic arterial hypertension, adults > 65 years old, or obesity) 11, 12 .

Nasopharyngeal and oropharyngeal swab samples were obtained from each participant before being 

General characteristics of the study population were represented as the mean ± standard deviation (SD) and percentages. Comparisons of the risk factors and the clinical findings among the groups were performed using a Chi-squared or Fisher's exact test for categorical variables and a t-test or Mann-Whitney U test for continuous variables. The odds ratios (OR) with Yates continuity correction were calculated for significant comparisons. Statistical analysis was carried out with the SigmaPlot v12.0 (Systat Software Inc., San Jose, CA, USA) software and a significance level of p <0.05 was considered significant.

One hundred patients were included in the study. Nineteen of them were index COVID-19 cases and eighty-one were close contacts ( Figure 1 ). The median age of the index cases was 41.7 years (range: 23-68 years) whereas the average age of the close contacts was 35.4 years old. Forty-seven were women.

Among the close contacts, 20.9% were nurses, 18.5% teachers, and 18.5% were students ( Table 1) . The most frequent comorbidity among the index patients was type 2 diabetes mellitus (T2DM) with two cases (10.5%), while arterial hypertension, dyslipidemia, and thyroid disease were present in only one indicated patient, respectively (5.2% each). Otherwise, the most frequent comorbidities amid the close contacts group were arterial hypertension with eight cases (9.8%), thyroid disease with six cases (7.4%), and T2DM with four cases (4.9%). Considering both index patients and close contacts, four (21%) index patients and thirty-three (40.7%) close contacts usually smoked and five (26.3%) index cases and thirtysix (44.4%) close contacts affirmed alcohol consumption ( Table 2 ). There was no statistical significance between the general characteristics or risk factors for COVID-19 between the groups of index cases and close contacts (p > 0.05). 

The mean time of the index COVID-19 patients' diagnosis after onset of symptoms was 2.7 ± 1.9 days. Table 3 show a summary of the results of index COVID-19 cases and their contacts. 

Only 67.1% of the study population had more than 2 weeks after their contact with a COVID-19 case.

From the one hundred participants, eighty-seven of them had rapid test results available. Regarding the close contacts of COVID-19 cases, thirteen (16%) showed positive results for IgM and/or IgG (23.1% for IgM, 7.7%, for IgG and 69.2% for IgG/IgM). 

C-S100 2 (2.5) 0 2 0 2 C-S110 3 (3.7) 0 3 0 3 C-S120 9 (11.1) 0 9 0 6 C-S130 4 (4.9) 0 4 0 4 C-S140 5 (6.2) 0 5 0 5 C-S150 5 (6.2) 2 3 4 1 C-S160 1 (1.2) 1 0 ND ND C-S170 2 (2.5) 0 2 ND ND C-S180 4 (4.9) 2 2 2 2 C-S190 3 (3.7) 3 0 3 0 † One contact linked to patient C-S110 was excluded because of insufficient data. ‡ Three close contacts did not have an antibody count because of an insufficient sample. They were associated with index COVID-19 patients C-S160 and C-S170. ND: no data. Table 2 There were twenty-nine symptomatic patients identified in the study and 24.1% had antibodies against SARS-CoV-2 (10.3% showed IgM, 3.4% IgG, and 17.2 % both IgG and IgM). From the five asymptomatic COVID-19 contacts, only two showed IgG/IgM antibodies ( Figure 1 ).

In this study, we evaluated laboratory, clinical, and epidemiological information of one hundred subjects, 5, 15 . An example of this observation is the study reported by Hong-Jun Zhang et al. 19 . In their study, the authors evaluated two hundred eighty-four close contacts from asymptomatic COVID-19 patients and identified only 2.7% of the close contacts as positive for SARS-CoV-2 20 . Therefore, as the low percentage of asymptomatic close contacts were positive for COVID-19, the probability of infectivity from asymptomatic SARS-CoV-2 might be weak 15 . However, even if the percentage of asymptomatic COVID-19 close contacts in our study was lower than the 17.9% reported on the "Diamond Princess" cruise, the non-evaluated SARS-CoV-2 asymptomatic patients may contribute to the rapid transmission and spread of the disease as the median duration of viral shedding is approximately 19 days, significantly longer than the 14 days in symptomatic patients 20 .

An important finding in our study was that the most common symptoms observed (headache, myalgia, odynophagia, cough, and rhinorrhea) in the contacts group were mostly presented without fever, contrary to other related studies in which fever is considered as a common symptom 5, 7, 20, 21 . Moreover, there was not a statistical difference in the presence of fever between the groups of contacts with or without SARS-CoV-2 infection (p = 0.078). It is important to note in our study that anosmia, conjunctivitis, chest pain, and irritability were symptoms exclusively presented by COVID-19 positive contacts (p < 0.05) but in the Mexican operational criteria they are grouped as the secondary symptoms group 11 . Considering our results and because the importance of these symptoms has been widely recognized, they should be considered as an essential criterion for the indication of SARS-CoV-2 testing by molecular diagnosis 22 .

Health workers constituted an important proportion in our study as they formed 32% of the total sample and from these, two COVID-19 indicated patients had the most SARS-CoV-2 positive close contacts.

This proportion was in agreement with the results of another study in which 25.3% of their close contacts were health care contacts 23 . Regarding only the close contacts with COVID-19, meet the Mexican operational definition for a COVID-19 suspected case did not significantly affect the rate of having a positive test for SARS-CoV-2 among the studied population, (OR: 3.1; 95% CI: 0.73 -13.6; p = 0.156).

As only five (14.7%) of our COVID-19 positive contacts met the operational criteria, the importance of close vigilance and screening of contacts of COVID-19 confirmed patients, even if they do not meet with that definition should be an essential measure to avoid the disease spreading. it is important to emphasize that the sample size in this study was small and therefore variations in the proportions could be found if our results are compared with large-scale investigations. On the same sense, because the most of the participants had no severe COVID-19-related symptoms is important to identify the COVID-19 population in which the serology test will be useful and if the rapid test should be used to reduce the false negatives rate that could occur with the RT-PCR method and/or as an evolution follow-up factor of disease.

There was a high proportion (42%) of close contacts of COVID-19 patients infected with SARS-CoV-2 and with less than two respiratory symptoms (67.6%). There were notable differences in the presence of anosmia, conjunctivitis, chest pain, and irritability symptoms between close contacts of COVID-19 patients, with and without SARS-CoV-2 infection. The average of SARS-CoV-2 infected close contacts by index COVID-19 case was 4.3 among the studied population, with the mean of time of positive test for SARS-CoV-2 being calculated as 18.9 days. The screening for SARS-CoV-2 by RT-PCR in close contacts of positive COVID-19 patients should be encouraged to avoid a source of spreading the infection and expanding of the disease.

Información General COVID-19 México

CoV-2: an Emerging Coronavirus that Causes a Global Threat

The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system

A study on infectivity of asymptomatic SARS-CoV-2 carriers

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures

Detection of serum IgM and IgG for COVID-19 diagnosis

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship

Coronavirus, diagnóstico y estrategias epidemiológicas contra COVID-19 en México

The Coronavirus Disease (COVID-19) Challenge in Mexico: A Critical and Forced Reflection as Individuals and Society. Frontiers in public health

Lineamiento estandarizado para la vigilancia epidemiologica y por laboratorio de la enfermedad respiratoria viral

Algoritmos interinos para la atención del COVID-19

A novel demographic-based model shows that intensive testing and social distancing are concurrently required to extinguish COVID-19 progression in densely populated urban areas

Recomendaciones para el embalaje y envío apropiado por vía terrestre, de muestras potencialmente infecciosas con agentes altamente patógenos. Pan American Health Organization, WHO

Asymptomatic SARS-CoV-2 Transmission from Community Contacts in Healthcare Workers. Annals of surgery

Pan American Health Organization W. Directrices provisionales de bioseguridad de laboratorio para el manejo y transporte de muestras asociadas al nuevo coronavirus 2019 (2019-nCoV). Pan American Health Organization

Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis

The reproductive number of COVID-19 is higher compared to SARS coronavirus

Asymptomatic and symptomatic SARS-CoV-2 infections in close contacts of COVID-19 patients: a seroepidemiological study

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature medicine

Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. The New England journal of medicine

Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2

The authors thank all the participants in the study for their willingness to provide data to generate knowledge related with COVID-19. We are also deeply thankful for the support during the patients' recruitment by authorities from Fresnillo city and from Zacatecas state. The assistance during patient recruitment provided by the Doctors: Edna Y Aguayo, Xiomara R Najera-Pargas, Carlos Gómez, and Juan C Alvarez-Castro, is also recognized. This work was funded in part by the Programa de Apoyos para el Fortalecimiento de Capacidades para el Diagnóstico de COVID-19-CONACYT. Grant ID: 314340 (A12 xii. 2020) to Margarita L Martinez-Fierro.

This work has been carried out in accordance with The Code of Ethics of the World Medical Association 

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.